| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.91 | 4e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 8e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |